Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
Completed · Not applicable
Conditions studied: Esophagitis, Malignant Neoplasm, Mucositis
In brief
This pilot clinical trial studies sensory evaluation of oral nutrition supplements in patients at risk for mucositis undergoing cancer treatment. Sensory evaluation may help to obtain input about new oral nutritional supplements that may increase nutrient intake and maintain or improve nutritional status, functional capacity, and quality of life in cancer patients.
Key facts
- Study ID
- NCT03228147
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 30
- Starts
- 2017-07-25
- Expected to finish
- 2017-10-31
- Last updated by the study team
- 2017-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Undergoing cancer treatment (chemotherapy, radiotherapy, and/or immunotherapy)
- At risk for mucositis OR with stage I mucositis or esophagitis (i.e. radiotherapy to the head, neck, esophagus or lung OR treatment with fluorouracil (5-FU) or other chemotherapeutic agents that are known to cause mucositis or esophagitis) or at risk for xerostomia
- Within the first 3 weeks of initiation of a new type of therapy
- Able to read and write in English
- Able to provide written informed consent
You may not qualify if…
- Food allergy to any component of the supplement
- Inability to taste or smell due to medication or health condition
Where it is running
- Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.